TGTX reports Monday, Mar 1, 2027, before the open. After the last 4 reports the stock moved +5.9%, −11.3%, +16.3%, +4.2% the next day.
TGTX is expected to report on Monday, Mar 1, 2027, before the open (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Nov 9, 2026 | 0.26 | 0.35 | +5.9% | +7.8% |
| Aug 3, 2026 | 0.44 | 0.05 | −11.3% | −4.4% |
| May 6, 2026 | 0.28 | 0.18 | +16.3% | +17.8% |
| Feb 26, 2026 | 0.33 | 0.14 | +4.2% | −1.6% |
| Nov 3, 2025 | 0.22 | 0.16 | −3.1% | −7.3% |
| Aug 4, 2025 | 0.29 | 0.17 | −18.0% | −23.7% |
| May 5, 2025 | 0.17 | 0.03 | −13.3% | −22.6% |
| Mar 3, 2025 | 0.17 | 0.15 | +14.4% | +27.8% |
Average move the next trading day over the last 8 reports: ±10.8% (4 of 8 up).
TGTX is in an uptrend, momentum firm. $66.12 is the level overhead; $60 the first support below.
TGTX at $63.34. Nearest resistance $66.12 (+4.4%). Nearest support $60.00 (−5.3%).
TGTX chart, levels and analysis · Latest analysis: TG Therapeutics (TGTX) stock analysis, November 20, 2026: bullish outlook with high conviction · Earnings this week
TGTX is expected to report on Monday, Mar 1, 2027, before the open.
TGTX reports before the open, US Eastern time.
After its report on Nov 9, 2026, TGTX moved +5.9% the next trading day.
Over the last 8 reports, TGTX moved 10.8% on average the next trading day, up 4 times out of 8.
Updated Nov 10, 2026 · Methodology · Research & education, not advice. Dates from company calendars via Yahoo Finance; moves from daily closes.
MarketCrew provides AI-generated market analysis and tools for informational and educational purposes only. Nothing here is investment advice or a recommendation to buy or sell any security, and it is not tailored to your circumstances. MarketCrew is not a registered investment adviser or broker-dealer. Markets involve risk, including the possible loss of principal — do your own research. © MarketCrew.